Omalizumab and new therapeutic targets in chronic spontaneous urticaria

• मुख्य लेखकों: Ana S. Pereira (लेखक), Joana Xará (लेखक), Duarte Flor (लेखक), Margarida Gonçalo (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Sociedade Portuguesa de Dermatologia e Venereologia, 2024-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Chronic spontaneous urticaria (CSU) is a common and distressing skin disease characterized by itchy wheals, angioedema, or both. There is currently no cure for CSU and symptomatic treatment is often insufficient. Omalizumab, a humanized anti-immunoglobulin (Ig) E monoclonal antibody, remains the onl...